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Abstract:  Increasingly over the past century, seasonal fish kills associated with toxic 
blooms of Prymnesium parvum have devastated aquaculture and native fish, shellfish, and 
mollusk populations worldwide. Protracted blooms of P. parvum can result in major 
disturbances to the local ecology and extensive monetary losses. Toxicity of this alga is 
attributed to a collection of compounds known as prymnesins, which exhibit potent 
cytotoxic, hemolytic, neurotoxic and ichthyotoxic effects. These secondary metabolites are 
especially damaging to gill-breathing organisms and they are believed to interact directly 
with plasma membranes, compromising integrity by permitting ion leakage. Several factors 
appear to function in the activation and potency of prymnesins including salinity, pH, ion 
availability, and growth phase. Prymnesins may function as defense compounds to prevent 
herbivory and some investigations suggest that they have allelopathic roles. Since the last 
extensive review was published, two prymnesins have been chemically characterized and 
ongoing investigations are aimed at the purification and analysis of numerous other toxic 
metabolites from this alga. More information is needed to unravel the mechanisms of 
prymnesin synthesis and the significance of these metabolites. Such work should greatly 
improve our limited understanding of the physiology and biochemistry of P. parvum and 
how to mitigate its blooms. 
Keywords:  harmful algal blooms (HAB); ichthyotoxins; prymnesins; Prymnesium 
parvum; polyketides 
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1. Introduction 
Several species of Prymnesium Massart are known to synthesize noxious chemicals as measured by 
their effects on erythrocytes and gill-breathing organisms (Table 1) [1–9]. This organism is especially 
notorious for seasonal harmful algal blooms (HAB) wherein cell densities increase rapidly with the 
accompanying presence of potent ichthyotoxins [3,10]. Persistent HAB involving Prymnesium can 
seriously threaten local wildlife, resulting in tremendous losses to the ecology and the economy of the 
affected regions [2,11]. Due to the breadth of its distribution and the frequency of toxic events, the 
majority of studies have implicated P. parvum and P. parvum f. patelliferum, which appear to be 
conspecific and may well represent alternate stages in a haploid-diploid life cycle [12]. The toxic 
principles of P. parvum f. patelliferum are similar in their effects and it is possible that they may be 
identical, or at least closely-related, compounds to those we review here [5,13]. The present review 
focuses on the toxic principles isolated from P. parvum, with exceptions noted. 
Table 1. Species of Prymnesium documented as toxic to aquatic life. Adapted from [1–4], and others. 
Species Source 
Prymnesium parvum  [2,3] 
P. parvum f. patelliferum  [5] 
P. calathiferum  [6] 
P. faveolatum  [7] 
P. saltans [7–9*] 
P. zebrinum  [7] 
*Organism described with one fish kill may have actually been P. parvum [2]. 
 
P. parvum is unicellular, ranging in size from 8–15 µm in length by 4–10 µm wide and having two 
flagella of roughly equal length positioned at the anterior end (Figure 1) [14–16]. These oblong cells 
possess two prominent ochre-colored chloroplasts positioned on either side of a centrally-located 
nucleus. Plastids of these golden (chromist) algae contain chlorophylls-a, -c, and an abundance of 
carotenoids [17–19]. A threadlike organelle, the haptonema, projects between the flagella and this 
structure is a unifying characteristic of the phylum [20]. This structure can vary greatly in length and in 
function between species; it is very short and non-coiling in P. parvum [14]. Proposed uses for the 
haptonema include it being a sensory device, which is used to attach to substrates or to capture and 
aggregate prey [21,22]. The haptonema is secretory in species of the related Chrysochromulina where 
glycolipid compounds are released from a region at the base of the organelle [21]. Structurally, the 
haptonema of P. parvum closely resemble those of Chrysochromulina, but the secretory attributes have 
not been demonstrated to our knowledge. Mar. Drugs 2010, 8                                    
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Figure 1. Light micrograph of two P. parvum cells (UTEX 2797). The haptonema (arrow) 
is shown projecting between the two flagella in the upper cell. 
 
 
P. parvum was first identified by Liebert and Deerns [23] in association with a bloom event in 
Denmark that reported diseased and dying fish. This alga was later confirmed with another toxic 
bloom [24]. However, one report suggested that P. parvum may have been responsible for earlier fish 
kills in the Baltic Sea during the late 1800’s [25]. The alga has since been extensively documented as 
being associated with seasonal toxic blooms and mass mortality events in aquaculture ponds and in 
native populations of gill-breathing animals. Recurring HAB of P. parvum are a nuisance on several 
continents (Figure 2). The majority of recorded blooms tend to be isolated to cooler waters located in 
the subtropical and temperate zones between the Tropic of Cancer and Arctic Circle and between the 
Tropic of Capricorn and Antarctic Circle. HAB of P. parvum often form in brackish estuarine waters, 
but a large number of blooms are known to occur in mainland fresh water reservoirs [27,28]. It is 
believed that this organism is principally of marine origin [29]. Although reports of P. parvum-related 
fish kills in freshwater reservoirs are growing in number, how this marine organism “invaded” 
freshwater reservoirs is presently unknown. Proposed vectors of transfer include contaminated bilge 
water, bird guano and encystment [11,15]. 
Figure 2. Global distribution of P. parvum by country where reported. Most blooms occur 
in temperate and subtropical zones. Adapted from [2,3,26], and others. 
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2. Prymnesins 
Toxin-based investigations with P. parvum and other toxic prymnesiophytes have been ongoing for 
90 years, and there are several reviews available (e.g., [3,26]). However, a major synthesis of the 
literature on prymnesins themselves has not been conducted in over 25 years [30–33]. Since last 
reviewed, two of these compounds have been isolated and chemically characterized [34–37], and 
phytochemical work indicates the existence of other toxic metabolites from this alga that are under 
study in various laboratories (e.g., [38,39]). Also, we now know much more about the ecology, 
molecular biology, and secondary metabolism of this alga that warrant further consideration in this 
context [40–43]. Surprisingly little is yet known regarding the molecular mechanisms of prymnesin 
synthesis, the mode of its transport, or the biological relevance of toxin production in this alga. 
2.1. Isolation and Characterization of Prymnesins 
The actual number of different substances that comprise the “prymnesins” is not presently known, 
but their broad range of biological activities support the notion that extracts from cells and from cell-
free supernatants are composed of a complex and diverse mixture of toxic metabolites [30–32,44–47]. 
For example, Ulitzur and Shilo [48] isolated 6 hemolytic fractions that were potentially chemically 
distinct from a hemolysin extracted by Kozakai et al. [49] and the toxic compound isolated by Paster [39]. 
Discrepancies between published investigations are likely due to the techniques used for the extraction 
of prymnesins, resulting in the isolation of unique sets of compounds that separate differently based on 
their affinity for different solvent(s). Therefore, caution must be exercised when interpreting data and 
comparing studies. Variations in toxicity reported for different extracts may well be attributed to the 
extraction methods resulting in extracts containing only a subset of all the possible toxic substances 
and activities. 
Prymnesins have been characterized as glycolipids, galactolipids, proteolipids and lipid-carbohydrate 
compounds [32,39,48–50]. Crude extractions have been performed with both whole cells and culture 
filtrates of P. parvum and many different approaches have been taken to separate the toxic principles. 
All of these methods are founded on the differential extraction of prymnesins using an organic mobile 
phase [32,47]. As a rule, the toxic fractions have been found to be the most soluble in polar organic 
solvents, and they demonstrate low affinity (and extremely low solubility) in highly non-polar 
organics. Toxins can be extracted, albeit very slowly, from cells using aqueous solutions; however, 
extracts from cells are greater than three times more concentrated when extracted with an organic 
solvent [32]. Shilo and Rosenberger [46] reported that prymnesins were not retained by either anion or 
cation exchange resins. However, Yariv and Hestrin [31] were able to obtain a concentrated sample of 
prymnesins by passing culture filtrates over precipitated Mg(OH)2, which suggests that some 
prymnesins demonstrate an affinity for this basic adsorbant material. 
Regarding the extraction of prymnesins from whole cells, cells are typically washed several times 
with cold acetone [34,35,39,46,48]. Shilo and Rosenberger [46] found that prymnesins are not soluble 
in acetone, which makes this an ideal organic solvent to eliminate interfering compounds including 
chlorophylls and accessory pigments. Afterwards, polar organics such as methanol, ethanol and/or  
n-propanol are usually employed to extract prymnesins from the cell remains [34,35,39,46,51]. In Mar. Drugs 2010, 8                                    
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some cases, multiple rounds of precipitation (e.g., using diethyl ether) are utilized to separate the toxic 
fractions; further purification of the target compounds can be achieved using column chromatography 
and/or additional rounds of partitioning between biphasic solvents (e.g., n-butanol) [32,39]. Prymnesin 
extracts have also been prepared from whole algal cell suspensions by liquid-liquid chromatography 
using a CHCl3:MeOH phase system, wherein the toxins are extracted into the lower phase that consists 
of a suspension of CHCl3/MeOH [48,52,53]. It is reported that prymnesins are most stable when they 
are stored at cooler temperatures as a dry powder; similarly, these extracts are more soluble in organic 
solvents than in water, and are less labile under acidic conditions near pH 5 [32,54]. 
It wasn’t until the mid-1990’s that we had the first glimpse of what two of these compounds 
actually look like. Prymnesin-1 (prym1) and prymnesin-2 (prym2) were meticulously isolated from 
whole algal cells by a group in Japan and these were the first toxic metabolites to be chemically 
characterized from any isolate of P. parvum using modern analytical methods (Figure 3) [34,35]. 
Purified prym1 and prym2 were shown to be potent polyketides with ichthyotoxic and hemolytic 
activities when present at nanomolar concentrations [34,35]. Prym1 and prym2 are ladder-like, 
polycyclic ethers that posses several noteworthy features. These complex compounds are remarkable 
in that they have double and triple carbon-carbon bonds in the unsaturated head and tail regions, an 
amino group, several chlorines, four 1,6-dioxadecalin units, and an assortment of sugar moieties 
[34,35]. Structurally, prym1 and prym2 are homologous compounds with a common head and 
backbone: they differ only in the number and in the type of sugars in the tail region, with prym2 
containing a rare L-xylose. Prym1 was shown to be slightly more polar (due to the additional sugar 
residues) and it elutes ahead of prym2 in reversed-phase C-18 chromatography [34,35]. 
Figure 3. Structures of prym1 and prym2 (inset). Synthesis studies have confirmed the 
absolute conformation of the ring series A-K and the sinistral (S) chiral centers at carbons 
14 and 85. Reproduced with minor modifications with permission from American 
Chemical Society [37]. 
 
 
The structural elucidation of prym1 and prym2 has been especially challenging due to their poor 
solubility in the deuterated organic solvents used with analytical methods such as proton nuclear 
magnetic resonance (NMR). However, chemical derivatives (e.g., N-acetylation) did demonstrate 
improved solubility and also provided a quantifiable shift in the mass/charge (m/z) for negative ion fast 
atom bombardment-mass spectrometry (FAB-MS) spectra [34]. However, chemical structures that 
have been elucidated from spectral analyses are often inaccurate and reassignments are common due to Mar. Drugs 2010, 8                                    
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the complexity of many secondary metabolites [55]. The backbone of prym1, comprised of rings A-N, 
was characterized using a computational approach [56]. Partial (in some cases, total) synthesis of 
compounds is also useful to reproduce structures and to determine the correct conformations. Recently, 
investigators have synthesized truncated ring models of prym1 and prym2. This work has led to the 
verification of the HI/JK rings, the conformation of the chiral centers at C14 and C85, and the 
reassignment of the juncture between rings E-F (Figure 3) [36,37].  
2.2. Putative Synthesis of the Polyketides, Prym1 and Prym2 
Very little is known about the synthesis of prymnesins in vivo. However, it is very likely that prym1 
and prym2 are derived from acetate-related metabolism based on what we know about their structures. 
In other organisms, the acetate pathway is responsible for the generation of fatty acids, as well as 
numerous secondary products that include polyketides and non-ribosomal peptides (Figure 4) [57,58]. 
Both primary and secondary metabolites synthesized in this pathway utilize 2-, 3-, and 4-carbon basic 
skeletal types coupled to coenzyme-A (CoA) [58,59]. Subunits are subsequently combined by 
successive decarboxylative condensations resulting in chain elongation. 
Figure 4. The acetate pathway is responsible for the synthesis of primary and secondary 
metabolites including fatty acids, polyketides and non-ribosomal peptides. Adapted from 
Mann [58], with permission from Oxford University Press.  
 
 
The biosynthesis of polyketides has many features in common with fatty acid synthesis and it uses 
similar, perhaps some of the same, enzymatic domains. Cane and Walsh [57] described polyketide 
synthase (PKS) as a modular “megaprotein” possessing a core catalytic domain and auxiliary (carrier) 
domains. The core domain contains the ketosynthase (KS), acyltransferase (AT) and the acyl carrier 
protein (ACP)—to which the growing polyketide molecule is tethered via an acyl-S-enzyme of the  
20 Å long phosphopantetheine arm. The AT domain catalyzes priming of the donor ACP with 
monomers, and the carbon-carbon bond-forming step is performed by the KS domain. The auxiliary 
domains encode for ketoreductase (KR), dehydratase (DH), and enoyl reductase (ER). The growing 
polyketide is handed over from one reactive thiol group to the next by transacetylation reactions. This 
process is repeated until the ultimate chain length has been achieved, whereupon thioesterase (TE) 
facilitates the removal of the polyketide by hydrolysis at the distal end of the pantetheine prosthetic 
group. The individual enzymes function to modify the elongating molecule before adding the next 
subunit. Chain elongation ceases when all of the “programmed” subunits are incorporated, resulting in 
a single-chain carbon backbone. Some PKSs also contain enzymes for cyclization (CYC) in addition to 
other secondary modifications (e.g., methylation) [58,59]. Note that cyclization may occur prior to or 
after the release of the polyketide from TE.  Mar. Drugs 2010, 8                                    
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A minimal PKS operon contains only the gene for KS, whereas diverse PKSs may contain all, parts 
or none of the respective domain sequences [59,60]. Structurally, prym1 and prym2 resemble other 
heterocyclic algal toxins produced by Type I PKSs, such as okadaic acid produced by marine diatoms, 
and brevetoxin and maitotoxin synthesized by the dinoflagellates Karenia brevis and Gambierdiscus 
toxicus, respectively [61,62]. These polyether polyketides are non-aromatic, which is characteristic of 
the Type I modular (non-iterative) PKSs found in bacteria, fungi, animals and some monocotyledonous 
plants. There is still some debate as to whether PKS associated with dinoflagellates is actually of 
bacterial origin [63]; in fact, the Type I PKS genes attributed to Prorocentrum have been isolated from 
associated bacteria (Roseobacter) [64]. Nevertheless, Type I PKS genes were recently isolated and 
sequenced from axenic cultures of P. parvum [41] and the related haptophyte Emiliania huxleyi 
(Haptophyta) [65], as well as from the green alga Chlamydomonas reinhardtii (Chlorophyta) [65]. 
In general, Type I PKS genes encode multiple catalytic domains organized into modules and each 
complete subunit may be composed of 2 or more modules (Figure 5) [64]. Each module contains all 
functional domains required for exactly one round of chain extension and modification. The 
complexity and diversity among polyketides and PKSs are a result of mutation, multiple gene 
duplications, deletions, and horizontal gene transfer [59]. We postulate that these modules might also 
potentially operate independently of one another in P. parvum to generate a diverse array of smaller, 
yet related polyether molecules, as was demonstrated in mutational analyses using a   
bacterial PKS [66]. 
Figure 5. Organization of a putative gene cluster encoding a Type I PKS subunit. The 
programming of complex polyketides is achieved by discrete modules containing multiple 
catalytic domains. Adapted from [59,60,66]. 
 
Type I PKS enzymes are analogous to the Type I FAS, and polyketide elongation is performed on 
an enzymatic framework prearranged into open reading frame modules encoding the mulitmeric 
protein complex (Figure 6). Because of this, it is likely that polyketide synthesis occurs in the stroma 
of plastids, which is known to be the case for FAS in green algae [67]. It should be noted that these 
mechanisms have not yet been elucidated for P. parvum. Glycosylation is a common modification of 
secondary metabolites, and this might be a mechanism for tagging prym1 and prym2 for transport. 
This process changes the physical and chemical properties of the compounds, their bioactivity and 
their sub-cellular localization [68]. Post-synthesis modifications (such as glycosylation) probably occur 
at the Golgi apparatus or endoplasmic reticulum, where many different molecules are tagged and 
packaged for transport [69]. More information regarding cellular location of polyketide synthesis, 
storage and transport would be of great importance in determining the biological significance of 
prymnesins to the alga (see later). 
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Figure 6. Type I PKS is a modular multiprotein complex. In this example, subunits are 
added successively by chain elongation tethered to an enzymatic framework. After the 
ultimate chain length is obtained, the polyketide is released, whereupon it undergoes 
secondary transformation, such as cyclization. Reproduced with minor modifications with 
permission from Elsevier [66]. 
 
 
Until recently, there were very few gene sequences available for P. parvum. An expressed sequence 
tag analysis of P. parvum identified a number of gene products that may be involved with acetate 
metabolism and polyketide synthesis [41]. Interestingly, these transcripts have a high sequence 
similarity to bacterial Type I PKS genes. More specifically, individual Type I PKS genes in P. parvum 
have their nucleotide sequence identities most similar to Roseovarius (a bacterium) and Nostoc  
(a cyanobacterium), and one PKS subunit is most closely related to that of a eukaryotic stramenopile 
[41]. In addition, there are at least 43 different unique genes whose products have been classified as 
being involved with secondary metabolite synthesis, catabolism and transport, including ACP 
synthase, oligoketide cyclase, and DH that are potentially relevant to polyketide synthesis. Another  
40 unigenes are classified as encoding proteins involved with lipid synthesis and transport, which 
could also have parallel roles in the manufacture of polyketides. Finally, there are a number of genes 
expressing vesicle transport-related proteins. Interestingly, the most abundantly expressed gene 
transcripts have no known sequence homology [41]. More work is needed in this area to determine 
which of these genes’ products directly participate in the synthesis or transport of prym1, prym2 and 
other toxic metabolites of P. parvum. 
The vitamins thiamine (B1) and cobalamin (B12) are required in culture media and are considered 
essential for the growth of most known P. parvum strains [22,32]. Several genes have been elucidated 
whose products are related to thiamine and cobalamin metabolism [41]. On the other hand, biotin (B7) 
and pantothenate (B5) have not been shown to be essential for growth, yet both vitamins are prosthetic Mar. Drugs 2010, 8                                    
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groups essential to the synthesis of primary and secondary metabolites. Acetyl-CoA carboxylase is a 
biotin-dependent enzyme in the acetate pathway and an essential component in the synthesis of fatty 
acids and polyketides. Similarly, pantothenate is required for the production of CoA, and in turn ACP. 
EST analyses indicate that P. parvum may possess several genes encoding enzymes involved in these 
B-vitamin synthetic pathways, and it is therefore likely that P. parvum is able to synthesize biotin and 
pantothenic acid de novo [41]. 
3. Modes of Prymnesin Toxicity 
Prymnesin extracts are reported to have saponin-like properties that are responsible for a host of 
deleterious effects including cytotoxicity, neurotoxicity, hemolysis, and ichthyotoxicity [30,31,33]. 
This broad spectrum of activities is owed in part to their amphipathic and ionophoretic properties [70]. 
Structurally, prym1 and prym2 are detergent-like compounds possessing both polar and non-polar 
ends. It should be noted that most toxicity studies have tested crude extracts, which contain toxic 
fractions as well as other substances. Therefore it is difficult to determine which compound(s) is (are) 
accountable for any individual biological effect. 
Cytotoxicity in the presence of prymnesins is described as possessing two distinct stages. The first 
response to exposure is cell swelling, which can be measured by the uptake of Trypan Blue dye; the 
second phase is death/lysis [51]. Cell swelling and lysis can take less than an hour or may take several 
hours depending on temperature and pH. Elevated pH and temperatures were found to be concomitant 
with an increase in cell lysis; however, this process could be halted by reversing the culturing 
conditions [51]. Based on observations with bacteria and membrane preparations, it has been proposed 
that prymnesins interact directly with specific components of the plasma membrane   
(e.g., membrane sterols) [32,71]. It is believed that prymnesins form micelles in aqueous solutions (due 
to their detergent-like properties) and that these aggregates assemble within the plasma membrane of 
exposed cells to form negatively-charged pores that are permselective to cations [31,50]. Moreover, 
the prymnesins have been shown to increase membrane conductance, which can be measured as a 
fluctuation in transmembrane ion concentrations [50,72]. Prymnesin toxicity is known to be dose-
dependent and it responds in a linear manner when analyzing log prymnesin concentration vs. log 
membrane conductance. 
Prymnesin extracts also possess potent neurological toxicity where it is thought that they interfere 
with the re-uptake of neurotransmitters at the post-neuronal synapse. Parnas and Abbott [73] 
demonstrated that this mechanism is carried out at the myoneural junction, where prymnesins inhibit 
acetylcholine and interfere with calcium signaling. Shilo [74] reported that an intravenous injection of 
prymnesins stops heart muscle by rapid depolarization and by altering the membrane permeability to 
calcium ions. In another study, an injection of prymnesin evoked muscle contractions, which was 
followed by the reversal of the acetylcholine-induced contractions and paralysis [32,75].   
An intravenous injection of prymnesins resulted in a sudden drop in blood pressure and respiratory 
arrest [76]. Meldahl and Fonnum [77,78] discovered that prymnesins from P. parvum f. patelliferum 
inhibit the sodium-dependent uptake of L-glutamate and -aminobutyric acid, and they enhance the 
calcium-dependent release of acetylcholine. In accordance, Mariussen et al. [79] found that 
prymnesins were responsible for the calcium-dependent release of glutamine at brain synaptosomes. Mar. Drugs 2010, 8                                    
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Prymnesins are also renowned for their potent erythrolytic capacity and prym1 and prym2 are 
reported to be 5,000 times more hemolytic than a plant-based saponin [62,80–82]. Crude prymnesin 
extracts can be isolated from either culture supernatants or cells, however cellular extracts exhibit a 
higher degree of hemolytic activity [31,47]. Prymnesins isolated from culture media yielded 
approximately 6700 hemolytic units (H.U.) per mg; by comparison, there was nearly six times this 
concentration found in cells, representing roughly 40,000 H.U. per mg [32]. 
The ichthyotoxic effects of prymnesins are by far the most noticeable, due to the frequency of 
blooms and distress caused by extensive fish kills. Many species of fish are documented as being 
sensitive to these compounds, as well as many amphibians, mollusks and crustaceans [33]. Prymnesins 
are noted as being especially lethal to gill-breathing organisms and they can be fatal at nanomolar 
concentrations [11,52,74,82]. After Gambusia were treated with prymnesins in addition to co-factors, 
their gills became darkly-stained with Trypan Blue within 5 min [1]. Interestingly, Shilo and Aschner 
[83] found that tadpoles (Bufo) were resistant to the effects of prymnesins shortly after metamorphosis, 
indicating that prymnesins affected tadpoles during the gill-breathing stage only. 
Exogenous prymnesins are not documented as being harmful to mammals or mature, lung-breathing 
amphibians [32]; toxic waters mistakenly used for irrigation and rinsing vegetables had no deleterious 
effects [53]. 
4. Variables Affecting the Presence and Toxicity of Prymnesins 
The presence of prymnesins differs with nutrient availability, salinity, light, temperature, pH, as 
well as growth stage of the alga [5,11,30,31,39,42,54,84,85]. Moreover, it has been demonstrated that 
actual prymnesin toxicity varies in dynamic physical and chemical conditions [28,46]. This is not 
unusual with toxin-producing microalgae. It is well known that growth conditions greatly affect the 
synthesis of secondary metabolites, and these compounds often increase in the presence of limiting 
conditions [86,87]. Interestingly, the intensity and range of noxious effects are also dependent on the 
activation of prymnesins in the presence of specific co-factors [88,89]. The ratio of hemolytic to 
ichthyotoxic activity is also variable and dependent on certain environmental factors; the hemolytic 
principle is not always accompanied by toxicity to fish [46,90]. These studies clearly illustrate that 
toxin synthesis and activation are likely very complicated processes that are potentially synergistic in 
response to environmental stimuli. As such, this may account for differences in observed toxicity 
under differing environmental and growth conditions. 
4.1. Nutrient Availability 
P. parvum can thrive in a wide range of physical conditions, but nutrient availability has been 
shown to greatly influence HAB and toxin formation in this organism. Agricultural effluents and 
eutrophication of waters are commonly implicated in a growth surge in P. parvum populations 
[11,91,92]. High nitrogen (in the form of nitrate or nitrite) and phosphorus (phosphate) concentrations 
support the rapid growth and formation of blooms that subsequently result in an imbalance of N and P 
sources. These limiting conditions ultimately slow the growth of P. parvum, which is usually 
accompanied by an increase in toxicity (as noted later) [5,30,93]. Mesocosm experiments over the 
course of five years indicated a reduction in toxicity in nutrient-replete conditions [43]. These Mar. Drugs 2010, 8                                    
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observations suggest that extracellular prymnesins decrease appreciably when growth and nutrient 
conditions are favorable; therefore, it has been proposed that prymnesin toxicity can be controlled by 
nutrient manipulation [94]. However, a decrease in exotoxins may also be concomitant with an 
increase in intracellular toxins (see later). 
Phosphorus and (to a lesser degree) nitrogen availability are probably among the most widely-
studied factors related to prymnesin toxicity. Shilo [74] was the first to demonstrate elevated toxicity 
of P. parvum in association with low phosphorus conditions, and this trend has been confirmed in 
subsequent studies [5,77,82,85,95]. Shilo [30] reported a 10- to 20-fold increase in the amount of 
intracellular prymnesins when grown in P-limited conditions; a rise in toxin concentration was also 
documented for culture supernatants. Johansson and Granéli [95] analyzed the effects of N and P 
levels on cell density, chemical composition and toxicity of P. parvum, being the first to show 
increased toxicity under N-limiting conditions. Hemolytic activity was observed regardless of the 
nutrient conditions, so they proposed that cell stress (resulting in lysis and death?) was the cause for 
increased toxicity rather than the direct involvement of either N or P in toxin synthesis per se [96]. 
This is also in agreement with analyses confirming increased toxicity in senescing/dying cultures of  
P. parvum (see later). 
The addition of a carbon source has also been shown to augment toxicity in populations of   
P. parvum. Dark-incubated cultures were able to grow in glycerol-supplemented media [84], and the 
addition of glycerol has been demonstrated to cause an increase in toxicity [97]. We postulate that this 
increased toxicity might be correlated to a surge in glycolytic activity from the exogenous carbon 
source. This would provide precursor molecules for the acetate pathway that might be used for 
polyketide synthesis. Conversely, glycerol and glucose have been shown to interfere with the 
formation of secondary metabolites in some organisms [86]. It is obvious that more information is 
needed to determine the roles of various nutrients in prymnesin toxicity and possible   
inhibitory pathways. 
Beyond being photosynthetic, P. parvum is also known to phagocytose bacteria and other 
photosynthetic algae, which may provide exogenous N, P and carbon sources in times of nutrient 
limitation [98,99]. Legrand et al. [94] demonstrated that P. parvum f. patelliferum utilizes various 
sources of phosphate including inorganic, dissolved, organic and particulate forms; similarly,   
P. parvum has been shown to utilize ammonia, methionine and ethionine as alternative N-sources 
[22,100]. Recent findings by Carvalho and Granéli [101] indicate that P. parvum is truly mixotrophic 
and therefore feeds heterotrophically under both nutrient-limiting conditions and in nutrient-replete 
cultures. Interestingly, bacterial suspensions of Proteus vulgaris and Bacillus subtilis decreased 
toxicity by 50% in one hour [83], suggesting that these bacteria may be capable of metabolizing at 
least some of the toxins [102]. 
4.2. Salinity 
Due to the predominance of blooms in low salinity and brackish water systems, many studies have 
examined the effects of salinity on prymnesin toxicity. The broad osmotic tolerances of P. parvum 
have been well-documented [5,22,97,103]. In most cases, P. parvum has been recorded in highly-
mineralized freshwaters between 3 and 8 ppt (e.g., [28]); some assert that P. parvum can grow almost Mar. Drugs 2010, 8                                    
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anywhere, in salinities ranging from 1 to 45 ppt [22,40,103]. However, low salinity conditions have 
been shown to have a negative effect on growth rates of P. parvum. Baker et al. [104] illustrated that 
there is a decrease in growth rate concurrent with a decrease in salinity, even when grown in nutrient-
sufficient conditions. Interestingly, Dickson and Kirst [27] postulated that the broad osmotic tolerance 
of P. parvum is related to their ability to synthesize a range of compatible solutes coupled to a partial 
exclusion of toxic ions. The fact that gene transcripts encoding various ion transporters were among 
the most highly-expressed ones in log-phase cultures of P. parvum, may also help to explain how this 
alga is able to handle such a broad range of salinities [41]. 
Specific ions may play a role in prymnesin toxicity, but these assessments are limited and 
conflicting data have been reported. Paster [32] noted that the optimum NaCl concentration for growth 
and toxin production in P. parvum is between 0.3–5% (=3–50 ppt) (see also [1]) Salt begins to inhibit 
toxicity at levels greater that 5–12% NaCl [32]. This is not surprising as this represents salt 
concentrations of 50–120 ppt, exceeding two to four times the salinity of open ocean seawater. Paster 
[32] found elevated ichthyotoxicity for cultures grown in 5% (0.75 ppt) artificial seawater (ASW that 
contained ~15 g/L salts) and the lowest toxicities are documented for cultures grown in 30% (4.5 ppt) 
ASW. Interestingly, there appeared to be an absence of ichthyotoxicity in salinities >30% seawater. 
However, a lack of extracellular bioactivity is not directly related to intracellular toxin production, as 
there are still large quantities of toxins able to be extracted from the cells themselves [32,76,105]. 
Shilo and Rosenberger [46] reported that the hemolytic property of prymnesins was inversely related 
to salinity with the highest hemolysis observed for cultures grown in 1% salt (=10 ppt). In contrast, 
Larsen and Bryant [40] found no significant differences in toxicity for P. parvum when grown at 
different salinities, which they felt could indicate metabolic differences among different strains of the 
alga. Since a decrease in toxicity in the culture media was reported to coincide with an increase in 
intracellular toxins [76], we conclude that both the cells and the supernatants need to be carefully 
analyzed in order to determine any relationships between salinity and toxicity. 
4.3. Light 
Light is a factor that is often associated with prymnesin toxicity, but published observations are 
somewhat inconsistent. P. parvum has been documented as naturally occurring in moderate-to-low 
light conditions, but some isolates have shown a preference for (and grow better with) higher 
illumination [40,106,107]. However, where P. parvum actually exists in the environment may be 
somewhat dependent on local community structure, which may also play a role in the stratification and 
distribution of P. parvum in the water column. 
Many studies have shown that both light quality and light intensity are physical properties that are 
essential for the synthesis and activity of prymnesins [28,47,74]. On the other hand, some have 
concluded that light is not necessary for toxin production in P. parvum [108]. Dark-grown cultures 
reportedly have a reduced amount of intracellular toxins, which supports the latter claim; but an 
increase in toxin concentration was detected later in the stationary phase of culture [89]. This finding is 
in agreement with growth studies that observed differences in toxicity and it suggests that toxic 
compounds are accumulating in the cells steadily throughout the exponential growth curve (see later). 
Since P. parvum is mixotrophic and can feed in the absence of light, these accounts suggest that light Mar. Drugs 2010, 8                                    
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may not be necessary as long as there is sufficient food to provide carbon skeletons for prymnesin 
synthesis. 
Interestingly, cultures that were grown under constant illumination demonstrated no ichthyotoxic 
activity, but did retain the hemolytic activity [106]. It was postulated that the ichthyotoxic principles 
may either be inactivated or they may degrade more rapidly than the compounds responsible for 
hemolysis [45]; alternatively, it is possible that multiple factors are responsible for hemolysis, some of 
which remain to be characterized. In accordance, exotoxins were inactivated after 90 min when treated 
with UV and visible wavelengths of light (255 nm and 400-520 nm, respectively) [107,109]; however, 
intracellular toxins were not affected, suggesting that these compounds are being protected by some 
mechanism or they may be stored in vesicles [97]. 
4.4. Temperature 
P. parvum is eurythermal, being capable of growing at temperatures ranging from 2–30 °C 
[22,28,39,83]. This has made it difficult to determine whether ambient temperature plays a significant 
role in prymnesin presence or toxicity. Globally, recurring HAB of P. parvum do not always occur at 
the same time of the year. Blooms in the southern United States appear throughout the fall and winter 
months [26]; in China, blooms form in the late spring and early fall [28]; and a summer bloom in 
Finland was characterized as having water surface temperatures around 20–25° C [53]. 
Similarly, optimum temperatures for growth and toxicity vary greatly among different geographic 
isolates of the alga. The optimum temperature of a strain from Denmark was around 26 °C, and growth 
was limited by temperatures near 10 °C [11]. In contrast, Larsen and Bryant [40] found that most (but 
not all) of the strains they studied had maximum growth rates at 15 °C. Given the broad temperature 
tolerances of P. parvum, there are no clear-cut correlations between specific temperatures and   
toxicity [30]. 
4.5. pH 
The various modes of prymnesin toxicity are also restricted to different pH ranges, with hemolysis 
and ichthyotoxicity highest during acidic and alkaline pH conditions, respectively. Prymnesins are also 
acid- and base-labile, which means that they are only functional under certain pH conditions [52]. 
Shilo and Rosenberger [46] demonstrated that an increase in pH to alkaline levels eliminated the 
hemolytic activity, but did not appear to affect ichthyotoxicity. In fact, these authors state that toxicity 
in fish requires a pH > 7.0, which is in agreement with the observations that toxic P. parvum occurs in 
Chinese waters ranging from pH 7.2 to 9.3 [28]. Ulitzur and Shilo [88] reported that activation of the 
ichthyotoxic property is dependent on cationic activation at a pH greater than 8.0 with maximum 
toxicity observed at pH 9.0 (see below). Conversely, hemolysis can occur in conditions as low as pH 5, 
with decreasing hemolytic activity with increasing alkalinity. These studies show that pH can greatly 
affect the range, nature and intensity of prymnesins’ toxic properties, which also suggests that 
numerous (and probably some unknown) compounds may be at work here. 
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4.6. Co-factors 
The primary reason why the presence of prymnesins and actual ichthyotoxicity are not necessarily 
related is because co-factors are required to “activate” prymnesins [5,30,31,85]. Furthermore, the type 
of activator determines the extent and severity of the toxic effects [89]. Toxicity to fish is greatly 
enhanced by the presence of Na
+, Ca
2+, and Mg
2+, as well as by antibiotics (e.g., streptomycin) and 
polyamines (e.g., spermine) [1,30,88,89,105]. Shilo and Rosenberger [46] established that divalent 
cations were more effective than monovalent ones in promoting ichthyotoxicity. These ion interactions 
may play a role in the aggregation, complexation and structural conformation of prymnesin molecules 
(as are common with polyether ionophores, e.g., the monensin-Na
+ complex [110]), which may in turn 
affect the ability of prymnesins to interact with specific components of the plasma membrane [1,70]. 
4.7. Biotic Factors 
Toxicity in this alga and in culture filtrates also varies with growth phase, i.e.,  lag phase, 
exponential phase and stationary phase cultures, in addition to the abiotic and community interactions 
mentioned [30,83]. While Paster [32] found a significant positive correlation between the 
concentration of P. parvum cells and the degree of exotoxins, some have suggested that factors 
necessary for growth and toxicity are regulated by different parameters [74,111]. In fact, Reich and 
Aschner [10] noted that concentration of prymnesins in the surrounding media is not always related to 
the intracellular concentrations of prymnesins. Extensive mortalities have been observed with low cell 
concentrations, and dense blooms of P. parvum have been documented as having no toxic effects 
[74,83]. Guo et al. [28] confirmed that the appearance of extracellular toxins from P. parvum has been 
shown to be independent of cell density, with the two parameters having no clearly-defined 
relationship. 
A reduction in ichthyotoxicity is typically observed during periods of rapid growth (e.g., 
exponential phase) and the effects of prymnesins are most obvious when populations of P. parvum 
reach limiting conditions (e.g., stationary phase) [28]. Similarly, Houdan et al. [4] reported that   
P. parvum cultures were less toxic to cultures of the brachiopod crustacean Artemia while in the 
exponential, growing phase. During the stationary phase (which happens to correspond to the highest 
cell concentrations and limiting conditions), they found complete mortality of Artemia nauplii. This is 
not surprising since secondary metabolism increases during periods when balanced growth has   
ceased [87]. This is often the case with eutrophication leading to surge in algal growth, which is 
subsequently followed by nutrient imbalance and limiting conditions (e.g., [93,95]). 
Berman [111] followed the total endo- and exotoxin content in growing cultures. In this study, it 
was noted that the concentrations of both hemolytic and ichthyotoxic compounds increased with 
culture age on a per-cell basis, implying that these compounds might be synthesized constitutively and 
accumulate as a result. In agreement, Paster [32] reported that prymnesins are synthesized throughout 
the alga’s life cycle, and are only released after cell death and disintegration of the cell components. 
This also lends more support to prymnesins serving a possible intrinsic function, because it would 
seem unlikely that cells would store waste products long-term (see later). Superficially, it would Mar. Drugs 2010, 8                                    
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appear that there is a difference in the presence of endo- and exotoxins, but more information is needed 
regarding the mechanism of release to make further conclusions on the roles of these compounds. 
Differences among published studies could be attributed to the methods of extraction, how cells and 
cell-free supernatants were being compared, how toxicity was quantified, the presence of cofactors, 
examining cultured vs. natural samples, differing geographic isolates, etc. 
5. Biological Relevance of Prymnesins 
It has been suggested that under certain conditions, the production of prymnesins may contribute in 
a number of ways toward improving the growth of the alga, or alternatively they may behave primarily 
as defensive compounds as are so many other secondary metabolites [112,113]. Prymnesins have been 
largely depicted as being extracellular (exo-) toxins, but the precise mechanisms of how these 
substances are released into the environment are not presently known [31,109]. Given their presence in 
water samples and in culture media, it is postulated that prymnesins could be either secreted, excreted 
or released into the environment as a result of cell lysis and death (or some combination thereof) 
[83,95,114]. Physiologically, these terms imply very different processes for the externalization of 
prymnesins, as well as the biological role(s) of prymnesins and the health of the alga.  
Prymnesins can be found in great abundance in the cells themselves as compared to culture filtrates, 
and this would lead one to believe that prymnesins are fulfilling some internal function; it is clearly not 
favorable to synthesize an abundance of energetically-expensive compounds without imparting some 
benefit to the organism producing the substance(s) in question [31,32,46,47]. Many secondary 
metabolites have intracellular roles as endotoxins, signaling compounds or storage products [87], and 
we postulate that prymnesins may have similar functions. 
The defensive properties of prymnesins have been well-defined, and it is obvious that the presence 
of prymnesins imparts numerous benefits to populations of P. parvum. Prymnesins have been shown to 
deter herbivores and reduce grazing, which also affects the feeding habits and viability of predator 
species [115–117]. For example, copepod feeding was lower in the presence of P. parvum f. 
patelliferum and the animals preferred non-toxic algae if given the choice [115,118,119]. Although it is 
not always clear whether lowered feeding is a result of the presence of exotoxins or the avoidance of 
noxious algae, these studies support the notion that toxin production may aid in the growth and 
survival of P. parvum by making the alga a less palatable option. 
Production of prymnesins may also confer P. parvum with the ability to capture prey organisms. 
Prymnesins are toxic to other algae and certain bacteria, and it was proposed that prymnesin toxicity 
was a mechanism for paralyzing prey prior to ingestion [38]. Later observations confirmed that 
prymnesins effectively paralyzed or killed prey organisms, which were rapidly phagocytosed thereafter 
by encroaching P. parvum cells [117,120,121]. Skovgaard and Hansen [114] pointed out that this is a 
functional advantage because P. parvum is otherwise unable to catch prey due to its short, stiff 
haptonema, as compared to many other haptophytes. Furthermore, if the haptonema is indeed secretory 
in this alga, it would be interesting to know the constituents of this secreted material to determine if 
they are related in any way to toxicity of P. parvum. 
Prymnesins as exotoxins also have allelopathic effects by the elimination of competing algal species 
[31,116,122,123]. In fact, Houdan et al. [4] noted that competing algae lost the ability to swim in the Mar. Drugs 2010, 8                                    
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presence of prymnesins. It has been suggested that prymnesins, as allelochemicals, may play a role in 
its ecological strategy due to the modest growth rate of P. parvum [103,124,125]. However, it cannot 
be stated unequivocally that prymnesins are allelochemicals until a mechanism of delivery is shown to 
correlate directly with any observed effects [126]. 
Finally, if prymnesins are released as a process of excretion, this would suggest that these 
substances are mere waste products. Prymnesins are also very likely to be released into the 
environment as a result of cell lysis. Future studies aimed at sub-cellular localization of the prymnesins 
and ones identifying potential metabolic and secretory pathways will be necessary to unravel the 
mechanisms by which these toxins wind up in the surrounding medium. This information would also 
be of significance in deciphering the incentives behind synthesizing prymnesins as well as in clarifying 
any of their intrinsic and extrinsic functions. 
6. Detection of Prymnesins 
Presently, there are no methods available for the specific detection of individual prymnesins 
themselves. The structural elucidation of the complex prym1 and prym2 molecules was a significant 
advancement in the study of this organism that has opened the door for the study of other toxic 
metabolites in P. parvum. Prym1 and prym2 were chemically characterized by positive-mode   
ESI-LC/MS and NMR [34,35]. While, these and related analytical methods are highly-sensitive and 
capable of validating both mass and structural features, generating procedures for mass spectra can be 
very complex, expensive, and time-consuming. Toxin-containing fractions must also be highly-
enriched and contain few interfering substances for confident detection and quantification. Moreover, 
there are no standards presently available for prym1, prym2, or for crude extracts of prymnesins. 
Consequently, such spectroscopic methods are not practical for prymnesin identification in natural or 
cultured samples. The chemical isolation of individual prymnesins has proved especially challenging, 
and new methods will need to be developed for the specific in vitro detection of toxic metabolites from 
this alga.  
Bioassay-based methods are widely used to detect the effects of prymnesins. These have been 
developed to quantify the various bioactivities of prymnesin extracts incorporating erythrocyte, 
crustacean, and fish model systems [32,40,127]. Due to the different modes of toxicity, ideally more 
than one type of assay should be employed to quantify the individual effects of toxin extracts [52,82]. 
It is also important to keep in mind that the various toxin activities are dependent on co-factors or 
electrolytes in the assay media, which may not be reflective of toxicity in native/environmental 
conditions. 
The hemolytic assay is considered very sensitive and requires 100-fold less prymnesins per unit 
volume than ichthyotoxicity-based assays [32]. Rabbit erythrocytes have been used for a number of 
analyses [32,39,45], while others have utilized other animal and fish as sources of red blood cells [31]. 
Hemolytic activity of prymnesins is dependent upon the presence of electrolytes in the assay medium, 
and it is estimated that approximately 5000 prymnesin molecules are needed per erythrocyte to initiate 
lysis [32]. The strain of P. parvum also appears to contribute to different results with this assay. For 
example, the cell concentration of P. parvum that elicits 50% hemolysis was approximately   
10,000 cells/mL compared to 50,000 cells/mL for P. parvum f. patelliferum [52]. Eschbach et al. [127] Mar. Drugs 2010, 8                                    
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used carp erythrocytes to test toxicity of whole cell extracts and compared results with saponin-based 
standards. In their assessment, hemolytic activity was recorded as a function of absorbance at 414 nm 
(from released hemoglobin) and the extent of hemolysis was sigmoidal as a function of prymnesin 
concentration. The hemolytic concentration necessary to elicit 50% hemolysis (HC50) for purified 
prym2 was 10.5 nM; hemolytic activity was unaffected by Ca
2+ but was affected by erythrocyte   
origin [128]. 
Toxicity of prymnesins can also be measured by their effects on crustaceans (e.g., Artemia) and fish 
(e.g., Gambusia) [88]. Both strain and growth phase of the alga may result in differences in observed 
toxicity. The lethal concentration of P. parvum cells leading to 50% Artemia mortality was recorded as 
being approximately ~1,000 cells/mL, whereas ~2,700 cells/mL was necessary when using a   
strain of P. parvum f. patelliferum [52]. With respect to growth phase of P. parvum, less than   
1.0 × 10
5 stationary-phase cells/mL were required for 50% Artemia mortality vs. 5.0 × 10
5 exponential-
phase cells/mL [4]. Clearly, the effects of prymnesins on crustaceans are not easily comparable and 
therefore may not represent equal measures of toxicity depending on growth phase and algal strain. 
The lethal concentration of purified prym2 with 50% fish mortality (LC50) is 300 nM without any  
co-factor, and 3 nM with the addition of 2.0 mM Ca
2+ [128]. The addition of a co-factor obviously 
promotes a 100-fold increase in toxicity in this system, which may be the cause of heightened toxicity 
in mineral-rich environments. 
Alternatively, as a substitute for measuring toxins, there are several methods available for the 
specific detection of P. parvum cells themselves. Traditionally, P. parvum identity is confirmed by 
microscopy, but many cell and molecular techniques are now available in addition to morphology-
based identifications. Oligonucleotide (rRNA) probes were designed for the detection of Prymnesium 
utilizing dot-blot hybridization and fluorescence in situ hybridization [129,130]. In addition, solid-
phase cytometry methods are available for the identification of P. parvum using fluorescently-labeled 
species-specific probes and monoclonal antibodies [131–133]. Conventional polymerase chain reaction 
(PCR)-based detection and quantification was made possible for several isolates of P. parvum using 
species-specific oligonucleotide primers [134]. These techniques are capable of detecting several 
geographic isolates of P. parvum,  a s  w e l l  a s  s o m e  i s o l a t es of the conspecific, P. parvum f. 
patelliferum. The most recently developed assays utilize real-time, qPCR technology for the detection 
and quantification of P. parvum [135,136]. These methods are particularly useful for the early 
detection of P. parvum when cell concentrations and toxic effects are below detectable limits. 
7. Conclusions and Future Prospects 
HAB events of the last century have greatly increased the awareness of prymnesins, toxic principles 
produced by the golden alga, P. parvum. It is obvious that many abiotic and biotic factors appear to be 
correlated with toxin presence within cells and in the surrounding medium, and overall prymnesin 
activity. Still it is difficult to generate models correlating prymnesin synthesis, toxicity and bloom 
formation partly because published reports are on disparate strains of P. parvum and toxin-based 
analyses are at times conflicting. Extreme differences can exist in toxin content and in toxin 
composition between different geographic isolates, and these differences are closely tied to the local 
environmental conditions and community ecology [87]. Therefore, it is believed that many of these Mar. Drugs 2010, 8                                    
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discrepancies can be attributed to inherent qualities of the various geographic strains for this widely-
distributed alga [40]. Moreover, the broad spectrum of toxic effects raises the question of how many 
compounds are actually responsible for toxicity in this alga, and we postulate that the type and number 
of prymnesins may expand in the future and may also differ among geographic isolates of P. parvum. 
The inactivation of prymnesins and eradication of P. parvum would be of great interest to fish and 
wildlife biologists working to mitigate HAB. The inactivation of prymnesin toxicity has been observed 
to occur under certain physicochemical conditions, but many methods are not feasible when balancing 
healthy fish culture and while retaining beneficial algae. Furthermore, it is difficult to determine which 
of these many toxic substances are being inactivated or if some of these toxins are merely inactive 
under the given conditions. Ammonium and copper sulfates are commonly employed for the 
eradication of P. parvum in fish culture ponds [28,89,137], but these chemicals have to be used at 
levels necessary to kill the alga without severely harming the fish [138]. Gou et al. [28] also tested the 
effectiveness of fertilizers and mud, but found that reducing the salinity to less than 2 ppt effectively 
suppressed algal growth without compromising the health of the fish. As was noted, P. parvum and its 
ensuing prymnesin toxicity might also be controlled by nutrient manipulation [94]. Finally, the use of 
flocculant clays has also shown some promise for the mitigation of P. parvum, but the clays appear to 
cause an increase in the presence of prymnesins, which is likely due to the stress and sedimentation 
from clay treatment [96]. 
Many variables play into observed differences in prymnesin toxicity, but the central issues lie with 
the specific extraction technique and the source of the toxin extraction (cells vs. culture filtrates). Each 
extraction technique potentially represents a different subset of toxic substances with variable activities 
and it is obvious that standard methods of extraction and quantification need to be established for any 
meaningful comparative purposes. Furthermore, we conclude that environmental parameters need to be 
established for individual geographic isolates of P. parvum so that we may better understand toxicity 
in this alga. Genome- and chemical-based investigations have presented avenues for probe 
development and gene expression analyses. The confirmation of the gene products thought to be 
involved in prymnesin synthesis would be of great interest, since they could potentially be manipulated 
using environmental controls and mutational analyses [87]. The sub-cellular location of prymnesins’ 
synthetic pathways, their sequestration and their mode of release into the environment would be of 
great value in determining the roles of toxin-production in this alga. It is clear that a more complete 
understanding of the molecular and biochemical triggers of prymnesin synthesis are needed in order to 
better monitor this and other HAB-forming organisms. 
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